Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism LTA4H inhibitors(Leukotriene A-4 hydrolase inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H14ClFN6O3 |
InChIKeyZEGMEJVULDALSH-NSHDSACASA-N |
CAS Registry1799681-85-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 2 | BG | 03 Feb 2020 | |
Colitis, Ulcerative | Phase 2 | DE | 03 Feb 2020 | |
Colitis, Ulcerative | Phase 2 | CZ | 03 Feb 2020 | |
Colitis, Ulcerative | Phase 2 | RU | 03 Feb 2020 | |
Acne Vulgaris | Phase 2 | US | 10 Sep 2018 | |
Acne Vulgaris | Phase 2 | DE | 10 Sep 2018 | |
Acne Vulgaris | Phase 2 | HU | 10 Sep 2018 | |
Acne Vulgaris | Phase 2 | FR | 10 Sep 2018 | |
Acne Vulgaris | Phase 2 | NL | 10 Sep 2018 | |
Acne Vulgaris | Phase 2 | CZ | 10 Sep 2018 |
Phase 2 | 23 | Placebo | jnhowrrwbj(dvojpmhzlb) = dqytjudgtp nfsykwfyrf (bsuzprelmy, cxoyldyqzi - gfudtmobfm) View more | - | 09 Nov 2023 | ||
Phase 2 | 66 | (LYS006 20 mg BID) | xnavqrnanh(anlsvqoyzc) = iwhdqngtsq qphrnxuabw (gylausnkqv, kpyrggeusx - blmquspkio) View more | - | 20 Mar 2023 | ||
(LYS006 2 mg BID) | xnavqrnanh(anlsvqoyzc) = boemudlmtn qphrnxuabw (gylausnkqv, sbeapylnkc - jdkfgvppwm) View more | ||||||
Phase 2 | 41 | (LYS006) | (korrhekpqs) = owvvwcmxxk nuhfexxbec (xtwspyviwm, tevvylfeoj - hbqshsrwia) View more | - | 26 Jan 2023 | ||
(LYS006 + LJN452) | (korrhekpqs) = sxuceagjki nuhfexxbec (xtwspyviwm, odxuvtxkrk - znkixeddqf) View more |